Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Advanced Imaging Technique Tracks Molecular Movement in Membranes of Living Cells

By BiotechDaily International staff writers
Posted on 20 Aug 2013
Image: The STED-RICS microscope scans the fluorescent cell membrane with a light spot and, thus, an image is recorded (Photo courtesy of the Karlsruhe Institute of Technology).
Image: The STED-RICS microscope scans the fluorescent cell membrane with a light spot and, thus, an image is recorded (Photo courtesy of the Karlsruhe Institute of Technology).
Cell biologists have combined two advanced imaging techniques to study the movement of molecules in the membranes of living cells and tissues.

Investigators at Karlsruhe Institute of Technology (Germany) combined raster image correlation spectroscopy (RICS) with stimulated emission depletion microscopy (STED) in imaging experiments on model membranes and live cells.

RICS is a powerful tool to study fast molecular dynamics such as protein diffusion or receptor–ligand interactions inside living cells and tissues. By analyzing time dependent spatial correlations of fluorescence intensity fluctuations from raster-scanned microscopy images, molecular motions can be revealed in a spatially resolved manner. However, because of diffraction-limited optical resolution, conventional raster image-correlation spectroscopy can only distinguish larger regions of interest and requires low fluorophore concentrations in the nanomolar range.

To counter the limitations of RICS the investigators combined it with STED microscopy. A STED microscope is a fluorescence microscope where the light spot scanning the fluorescence image can be reduced considerably. This method has already been used successfully to reach a maximum resolution in the imaging of cells.

In the current study, which was published in the June 27, 2013, online edition of the journal Nature Communications, the investigators showed that STED-RICS microscopy offered enhanced multiplexing capability because of enhanced spatial resolution as well as access to 10–100 times higher fluorophore concentrations.

“This means that the STED-RICS method can be used to derive from any fluorescence image a highly resolved map of the number and movability of the marked molecules in the area scanned by the spot,” said senior author Dr. Gerd Ulrich Nienhaus, professor of applied physics at the Karlsruhe Institute of Technology.

Application of the STED-RICS technique will enable investigators to precisely and quantitatively track the movements of cell membrane lipids and receptors. The action of many drugs is linked to the interactions among these molecules. “About every second medical substance influences signal transduction of G-protein coupled receptors, an important subclass,” said Dr. Nienhaus.

Related Links:
Karlsruhe Institute of Technology


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.